Crossmark

Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

Crossref DOI link: https://doi.org/10.1186/s12885-017-3859-3

Published Online: 2017-12-21

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ge, Chunlei

Li, Ruilei

Song, Haifeng

Geng, Tao

Yang, Jinyan

Tan, Qinghua

Song, Linfeng

Wang, Ying

Xue, Yuanbo

Li, Zhen

Dong, Suwei

Zhang, Zhiwei

Zhang, Na

Guo, Jiyin

Hua, Lin

Chen, Siyi

Song, Xin